To investigate the development of polypoidal lesions using indocyanine green angiography (IA) in eyes with typical age-related macular degeneration (AMD). We retrospectively reviewed the medical ...

For patients with polypoidal choroidal vasculopathy, intravitreal ranibizumab may help resolve retinal fluid and increase visual acuity in the short term, but large polyps and pigment epithelial ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The ...

Please provide your email address to receive an email when new articles are posted on . Intravitreal ranibizumab significantly improved visual acuity in eyes with polypoidal choroidal vasculopathy but ...

Researchers have found that idiopathic polypoidal choroidal vasculopathy (PCV) has significant clinical differences to neovascular age-related macular degeneration (AMD) and suggest that it should be ...

Ranibizumab, in combination with prompt verteporfin photodynamic therapy, is more effective in treating polypoidal choroidal vasculopathy compared with ranibizumab monotherapy, according to a study ...

Find out how higher dose aflibercept may reduce injection burden while preserving vision in retinal vasculopathy.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new data from the AVONELLE-X and SALWEEN studies of Vabysmo ® (faricimab-svoa), presented at the 25th Euretina ...

"Polypoidal choroidal vasculopathy"DelveInsight's,“Polypoidal choroidal vasculopathy - Pipeline Insight, 2025” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in ...

– In AVONELLE-X, the largest long-term extension trial in wet AMD, disease control and durability were maintained over 4 years, with nearly 80% of patients on extended dosing by study end – – Over 60% ...